1 |
Chen X, Wu W, Wang Y, Zhang B, Zhou H, Xiang J, Li X, Yu H, Bai X, Xie W, Lian M, Wang M, Wang J. Development of prognostic indicator based on NAD+ metabolism related genes in glioma. Front Surg 2023;10:1071259. [PMID: 36778644 DOI: 10.3389/fsurg.2023.1071259] [Reference Citation Analysis]
|
2 |
Helman T, Braidy N. Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders. Drugs Aging 2023;40:33-48. [PMID: 36510042 DOI: 10.1007/s40266-022-00989-0] [Reference Citation Analysis]
|
3 |
Qin Y, Chen ZH, Wu JJ, Zhang ZY, Yuan ZD, Guo DY, Chen MN, Li X, Yuan FL. Circadian clock genes as promising therapeutic targets for bone loss. Biomed Pharmacother 2023;157:114019. [PMID: 36423544 DOI: 10.1016/j.biopha.2022.114019] [Reference Citation Analysis]
|
4 |
Huang J, Gao M, Li D, Zhan S, Qiu Y, Chen B, Cao T, Chen Z. Nicotinic acid protected germinal vesicle oocyte meiosis against toxicity of benzo(a)pyrene during maturation.. [DOI: 10.21203/rs.3.rs-2236225/v1] [Reference Citation Analysis]
|
5 |
Larrea D, Tamucci KA, Kabra K, Velasco KR, Yun TD, Pera M, Montesinos J, Agrawal RR, Smerdon JW, Lowry ER, Stepanova A, Yoval-sanchez B, Galkin A, Wichterle H, Area-gomez E. Altered MAM function shifts mitochondrial metabolism in SOD1-mutant models of ALS.. [DOI: 10.1101/2022.09.22.508778] [Reference Citation Analysis]
|
6 |
Zhu Y, Xu P, Huang X, Shuai W, Liu L, Zhang S, Zhao R, Hu X, Wang G. From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases. Front Pharmacol 2022;13:920113. [DOI: 10.3389/fphar.2022.920113] [Reference Citation Analysis]
|